1. Home
  2. DUO vs TNON Comparison

DUO vs TNON Comparison

Compare DUO & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DUO

Fangdd Network Group Ltd.

HOLD

Current Price

$1.13

Market Cap

7.5M

Sector

Finance

ML Signal

HOLD

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$0.80

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DUO
TNON
Founded
2011
2012
Country
China
United States
Employees
N/A
27
Industry
Real Estate
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
9.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
DUO
TNON
Price
$1.13
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
47.8K
138.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$19.56
Revenue Next Year
N/A
$71.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.64
52 Week High
$5.34
$5.85

Technical Indicators

Market Signals
Indicator
DUO
TNON
Relative Strength Index (RSI) 46.66 46.44
Support Level $1.01 $0.72
Resistance Level $1.20 $0.89
Average True Range (ATR) 0.08 0.05
MACD 0.02 0.01
Stochastic Oscillator 42.66 45.43

Price Performance

Historical Comparison
DUO
TNON

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Share on Social Networks: